eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 4 : 392-397 doi: ijmmas.2005.392.397
Research Article
Antimicrobial Potentials of (UDA) Xylopia aethopica and Occimum gratissimum L. on Some Pathogens of Man
Published
Dec. 30, 2005
Abstract

Antimicrobial effect of uda (Xylopia aethopica) and nchuawu (Occimum gratissimum) on some pathogens: Proteus mirabilis, Esherichial coli, Staphylococcus aureus and Candida albicans were carried out. Different solvents used for the extraction of the plant were water (hot and cold) and ethanol. The antibacterial effect of Xylopia aethopica of its aqueous (cold) and (hot) showed inhibition on Proteus mirabilis, Staphylococcus aureus and Candida albicans with MIC of 0.0625 on Proteus mirabilis of aqueous cold and 0.25 of aqueous hot, 0.0625 on Staphylococcus aureus of aqueous cold and 0.0625 on aqueous hot, 0.25 on Candida albicans of aqueous cold extract and 0.5 on aqueous (hot) extract and no inhibition on Esherichial coli. Occimum gratissimum showed inhibition on Proteus mirabilis, Esherichial coli and Staphylococcus aureus of it`s ethanolic and aqueous extracts. Proteus mirabilis on ethanolic extract with the MIC of 0.5, Esherichia.coli with 0.125 and Staphylococcus aureus with 0.25. the aqueous cold extract on, Proteus mirabilis with MIC of 0.125 on Esherichial coli with 0.5 and on Staphylococcus aureus 0.25 while aqueous hot with Proteus mirabilis with 0.125, Esherichial coli with 0.25 and Staphylococcus aureus with 0.25 and no inhibition on Candida albicans. This justifies the therapeutic uses of Occimum gratissiumum and Xylopia aethopica. Further investigation can combine the plants extracts for possible synergetic effects.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Wearable Devices for Chronic Disease Monitoring: Transforming Healthcare Through Continuous Digital Health Surveillance
22-26
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Internet of Medical Things in Healthcare Delivery: Transforming Modern Healthcare Through Connected Technologies
1-6
Factors Influencing Specialty Choice Among Medical Graduates: Determinants, Trends, and Implications for Healthcare Workforce Planning
27-32
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.